Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
PLN 2M - 2M
Notice Type:
Contract Notice
Published Date:
19 July 2021
Closing Date:
20 August 2021
Location(s):
PL426 Koszaliński (PL Poland/POLSKA)
Description:
Supply of cytostatics, supportive drugs in oncology, medicines, conditioners, infusion fluids, insulin, diagnostic tests to the hospital pharmacy of the Specialized Tuberculosis and Langy Diseases Team in Koszalin...

1. The subject of the order is the delivery of cytostatics, supportive drugs in oncology, medicines, conditioners, infusion fluids, insulin, diagnostic tests to the hospital pharmacy of the Specialized Tuberculosis and Langen Diseases Team in Koszalin to the extent specified in the SWZ.

2. The Contracting Authority shall extract an order for ten stand-alone parts (each part is referred to as “Task”):

— Task I — cytostatics,

— Task II — cytostatics,

— Task III — cytostatics,

— Task IV — an auxiliary drug in oncology,

— task V — medicines, conditioners, supportive drugs in oncology,

— Task VI — medicines,

— Task VII — diagnostic tests,

— Task VIII — medicines,

— Task IX — infusion fluids,

— Task X — an auxiliary drug in oncology.

2. Requirements for the subject of the order include Chapter IV of the SWZ.

Task I — Cytostatics

Requirements for the item of the order include Chapter IV of the SWZ.

The subject of the order is specified in the assortment and price form constituting Annex No 2/I to the SWZ. The quantities given are the average annual demand over 12 months. The Contracting Authority shall allow a modification of the quantity of medicinal products processed for individual items, indicating that the gross value of the contract concluded must not be increased. The actual demand will be due to the current needs of the Ordering Party.

Task X — Supportive drug in oncology

Requirements for the item of the order include Chapter IV of the SWZ.

The subject of the order is specified in the assortment and price form constituting Annex No 2/X to the SWZ. The quantities given are the average annual demand over 12 months. The Contracting Authority shall allow a modification of the quantity of medicinal products processed for individual items, indicating that the gross value of the contract concluded must not be increased. The actual demand will be due to the current needs of the Ordering Party.

Task II — Cytostatics

Requirements for the item of the order include Chapter IV of the SWZ.

The subject of the order is specified in the assortment and price form constituting Annex No 2/II to the SWZ. The quantities given are the average annual demand over 12 months. The Contracting Authority shall allow a modification of the quantity of medicinal products processed for individual items, indicating that the gross value of the contract concluded must not be increased. The actual demand will be due to the current needs of the Ordering Party.

Task III — Cytostatics

Requirements for the item of the order include Chapter IV of the SWZ.

The subject of the order is detailed in the assortment and price form constituting Annex 2III to the SWZ. The quantities given are the average annual demand over 12 months. The Contracting Authority shall allow a modification of the quantity of medicinal products processed for individual items, indicating that the gross value of the contract concluded must not be increased. The actual demand will be due to the current needs of the Ordering Party.

Task IV — Supportive drug in oncology

Requirements for the item of the order include Chapter IV of the SWZ.

The subject of the contract is specified in the assortment and price form constituting Annex No 2/IV to the SWZ. The quantities given are the average annual demand over 12 months. The Contracting Authority shall allow a modification of the quantity of medicinal products processed for individual items, indicating that the gross value of the contract concluded must not be increased. The actual demand will be due to the current needs of the Ordering Party.

Task V — Drugs, conditioners, supportive drugs in oncology

Requirements for the item of the order include Chapter IV of the SWZ.

The subject of the order is specified in the assortment and price form constituting Annex No 2/V to the SWZ. The quantities given are the average annual demand over 12 months. The Contracting Authority shall allow a modification of the quantity of medicinal products processed for individual items, indicating that the gross value of the contract concluded must not be increased. The actual demand will be due to the current needs of the Ordering Party.

Task VI — Drugs

Requirements for the item of the order include Chapter IV of the SWZ.

The subject of the contract is specified in the assortment and price form constituting Annex No 2/VI to the SWZ. The quantities given are the average annual demand over 12 months. The Contracting Authority shall allow a modification of the quantity of medicinal products processed for individual items, indicating that the gross value of the contract concluded must not be increased. The actual demand will be due to the current needs of the Ordering Party.

Task VII — Diagnostic tests

Requirements for the item of the order include Chapter IV of the SWZ.

The subject of the order is specified in the assortment and price form constituting Annex No 2/VII to the SWZ. The quantities given are the average annual demand over 12 months. The Contracting Authority shall allow a modification of the quantity of medicinal products processed for individual items, indicating that the gross value of the contract concluded must not be increased. The actual demand will be due to the current needs of the Ordering Party.

Task VIII — Drugs

Requirements for the item of the order include Chapter IV of the SWZ.

The subject of the order is specified in the assortment and price form constituting Annex No 2/VIII to the SWZ. The quantities given are the average annual demand over 12 months. The Contracting Authority shall allow a modification of the quantity of medicinal products processed for individual items, indicating that the gross value of the contract concluded must not be increased. The actual demand will be due to the current needs of the Ordering Party.

Task IX — Infusion fluids

Requirements for the item of the order include Chapter IV of the SWZ.

The subject of the contract is specified in the assortment and price form constituting Annex No 2/IX to the SWZ. The quantities given are the average annual demand over 12 months. The Contracting Authority shall allow a modification of the quantity of medicinal products processed for individual items, indicating that the gross value of the contract concluded must not be increased. The actual demand will be due to the current needs of the Ordering Party.

Download full details as .pdf
The Buyer:
Specjalistyczny Zespół Gruźlicy i Chorób Płuc
CPV Code(s):
33600000 - Pharmaceutical products